Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,875
datasets available to search
ShareScore release 0.9.0
Dataset results
5,875 results for “lively”
Fig. 1 in Evidence of Stress Recovery in Free-Living Ciliate Colpoda cucullus: The Repair Capability of Resting Cysts to Damage Caused by Gamma Irradiation
Fig. 1. Excystment assay of Colpoda wet cysts (A) and dry cysts (B). 'Non-irradiated' indicates non-irradiated cysts; 'irradiated' indicates cysts irradiated at 4000 Gy, and 'irradiated-incubated' indicates cysts irradiated at 4000 Gy and incubated for 12 hours before the induction of excystment. Time indicates the number of hours after the induction of excystment. Columns and attached bars correspond to the means and standard errors, respectively, of six measurements. Asterisks and double asterisks represent significant differences at p <0.05 and p <0.01 (Mann-Whitney U test), respectively.
Fig. 5 in Small Free-Living Heterotrophic Flagellates from Marine Sediments of Gippsland Basin, South-Eastern Australia
Fig. 5. Dendrogram showing the Bray-Curtis similarity (%) between the communities from 41 habitats; taxonomic information based on species. Species data used for this analysis were from Lee and Patterson (1998), Al-Qassab et al. (2002), Lee et al. (2003, 2005), Lee (2002b, 2006a, b, 2008, 2012), Schroeckh et al. (2003), Aydin and Lee (2012) and the present study. MB – marine benthic habitats, MP – marine planktonic habitats, FB – freshwater benthic habitats, FP – freshwater planktonic habitats. * indicates Australian sites.
Fig. 2. a in Small Free-Living Heterotrophic Flagellates from Marine Sediments of Gippsland Basin, South-Eastern Australia
Fig. 2. a – Chilomastix cuspidata, showing general appearance of cell; b – Goniomonas amphinema, showing general appearance of cell; c – G. pacifica, note two flagella diverging; d – Percolomonas similis, note ventral groove; e – Bodo platyrhynchus; f – Neobodo curvifilus; g – N. saliens; h–i – Hemistasia phaeocysticola, note a papillum (arrow); j – Bordnamonas tropicana, showing general appearance and mouth (arrow); k – Rhynchomonas nasuta; l–o – Rhynchobodo simius; l – tubular ingestion organelle (arrow); m, o – showing groove; n – general appearance of cell; p–q – Rhynchopus amitus; r–s – Spironema multiciliatum; t – Amastigomonas debruynei, general appearance of cell; u – Amastigomonas mutabilis, note anterior flagellum projecting from sleeve and recurrent flagellum; v – Apusomonas sp.; w – Psammosa unguis nov. comb., general appearance of cell; x–y – Mantamonas plastica; x – note anterior flagellum (arrow) and y – ventral depression. All micrographs are DIC images. Scale bar: 5 µm for all figures.
Fig. 1. a in Small Free-Living Heterotrophic Flagellates from Marine Sediments of Gippsland Basin, South-Eastern Australia
Fig. 1. a – Chilomastix cuspidata, b – Rhynchopus amitus, c – Spironema multiciliatum, d – Psammosa unguis nov. comb., e – Apusomonas sp., f – Rhynchobodo formica, g – Mantamonas plastica, h – Roombia truncata, i – Thaumatomastix setifera, j – Ancyromonas impluvium nov. spec., k – Helkesimastix faecicola, l – Kurnaimonas celeris nov. spec., m – Sinistermonas sinistrorsus nov. spec., n – Kiitoksia kaloista, o – Protist '1'. Scale bar: 10 µm for all figures.
Fig. 4. a in Small Free-Living Heterotrophic Flagellates from Marine Sediments of Gippsland Basin, South-Eastern Australia
Fig. 4. a – Carpediemonas membranifera; b – Kipferlia bialata; c – Discocelis saleuta, note a short flagellum; d – Metopion fluens, showing general appearance of cell, note shorter flagellum (arrow); e–f – Kurnaimonas celeris nov. spec., showing general appearance of cell; g – Pseudophyllomitus granulatus; h – Helkesimastix faecicola, showing general appearance and note short flagellum (arrow); i – Metromonas grandis, showing general appearance of cell and note the folded margin on the left side and short flagellum (arrow); j – Metromonas simplex, showing general appearance of cell and note short flagellum (arrow); k – Kiitoksia kaloista, showing two flagella and note short flagellum (arrow); l – Sinistermonas sinistrorsus nov. spec., showing general appearance of cell, and note flagellar insertion and beating pattern of anterior flagellum; m – Telonema subtilis, showing general appearance; n – Protist '1'. All micrographs are DIC images. Scale bar: 5 µm for all figures.
Fig. 3. a–b in Small Free-Living Heterotrophic Flagellates from Marine Sediments of Gippsland Basin, South-Eastern Australia
Fig. 3. a–b – Rhynchobodo formica; c – Massisteria marina, general appearance of cell showing pseudopodia and flagella (arrow); d–f – Cercomonas sp.; d – note two acronematic flagella; e – general appearance; f – note flagellar orientation; g–h – Roombia truncata, note cell attached to the substrate by the tip of the posterior flagellum and note extrusomes; i – Protaspa obliqua, note anterior protrusion; j–k – Thaumatomastix setifera, note spines around the body; j – general appearance of cell; k – ventral face showing a deep groove and pseudopodia; l–m – Ancyromonas sigmoides of different cells; l – note slightly thick anterior flagellum with acronematic tip and broad rostrum; m – note thick anterior flagellum and acute rostrum; n–p – Ancyromonas impluvium nov. spec., showing general appearance of cell and note flagellar insertion. All micrographs are DIC images with the exceptions of (d) and (p) which are phase contrast images. Scale bar: 5 µm for all figures.
РИС. 5. Живые особи Arion vulgaris на грунтовой тропинке (фото И.Н. Субботиной) FIG. 5. Live specimens of Arion vulgaris on a dirt trail (photo by I.N. Subbotina) in Новые находки синантропных слиЗней Limacus maculatus и Arion vulgaris (Mollusca, Gastropoda, Stylommatophora) в Беларуси
РИС. 5. Живые особи Arion vulgaris на грунтовой тропинке (фото И.Н. Субботиной) FIG. 5. Live specimens of Arion vulgaris on a dirt trail (photo by I.N. Subbotina)
РИС. 3. Внешний вид Arion vulgaris иЗ г. Минска (фото И.Н. Субботиной). FIG. 3. Live specimen of Arion vulgaris from the Minsk city (photo by I.N. Subbotina). in Новые находки синантропных слиЗней Limacus maculatus и Arion vulgaris (Mollusca, Gastropoda, Stylommatophora) в Беларуси
РИС. 3. Внешний вид Arion vulgaris иЗ г. Минска (фото И.Н. Субботиной). FIG. 3. Live specimen of Arion vulgaris from the Minsk city (photo by I.N. Subbotina).
РИС. 1. Внешний вид Limacus maculatus иЗ окрестностей г. ГомелЯ. FIG. 1. Live specimen of Limacus maculatus from the vicinity of Gomel city. in Новые находки синантропных слиЗней Limacus maculatus и Arion vulgaris (Mollusca, Gastropoda, Stylommatophora) в Беларуси
РИС. 1. Внешний вид Limacus maculatus иЗ окрестностей г. ГомелЯ. FIG. 1. Live specimen of Limacus maculatus from the vicinity of Gomel city.
Table 1 in Latitudinal Diversity Gradients in Free-living Microorganisms - Hoogenraadia a Key Genus in Testate Amoebae Biogeography
<p><b>Table 1.</b> Characters and distribution of six species of the genus <i>Hoogenraadia</i> (L – length, W – width). Many of the earlier papers do not report a sample size for number of tests measured – so it is possible that some of these data may be based on a very low sample size.</p><table><tbody><tr><th>Species</th><th>Size <b>(</b>µm<b>)</b></th><th>Distribution regions and publication</th><th>Habitats</th></tr></tbody><tbody><tr><th><i>H. africana</i></th><td>L = 95–115, W = 47–60</td><td>Moyen-Congo (Gauthier-Lièvre and Thomas 1958), Guinea and Equatorial Guinea (Golemansky 1962), Brasil (Leiptniz <i>et al</i>. 2003), China (Qin <i>et al</i>. 2011)</td><td><i>Sphagnum</i>, water, river, forest marsh</td></tr><tr><th><i>H. asiatica</i></th><td>L = 95, W = 70</td><td>China (Wang and Min 1987)</td><td>Quaternary deposit</td></tr><tr><th><i>H. cryptostoma</i></th><td>L = 130–140, W = 105–110</td><td>Moyen-Congo (Gauthier-Lièvre and Thomas 1958), States of Parana, Mato Grosso du Sul, Brasil (Velho <i>et al</i>. 1996, 2000)</td><td>Swamp quite shady in the bed of a stream</td></tr><tr><th><i>H. humicola</i></th><td>L = 143–146, W = 96–100</td><td>Nepal, Himalayas (Bonnet 1977, 1978), Philippines (Bonnet 1980), Cote d’Ivoire, Africa (Bonnet 1976, 1978), Tonga and Western Samoa Islands (Korganova 1994), China (this paper)</td><td>Soils rich in organic debris in forest-gallery backwaters. The ground litter and sublitter horizons of white subtropical soils</td></tr><tr><th><i>H. ovata</i></th><td>L = 60–67, W = 36–39</td><td>Cote d’Ivoire, Africa (Bonnet 1976)</td><td>Soils rich in organic debris in forest-gallery backwaters</td></tr><tr><th><i>H. sylvatica</i></th><td>L = 82–93, W = 60–70</td><td>Punta Lara Province of Buenos Aires, Argentina (Vucetich 1974)</td><td>Moss in marginal forest</td></tr></tbody></table>
Live-Cell Imaging of MCF10A Cells Treated with EGF or PBS
<p>MCF10A cell culture and experimental procedures were conducted based on established methodologies (10.1038/s42003-022-03975-9). For routine maintenance and passaging, cells were cultured in a growth medium composed of DMEM/F12 (Invitrogen, #11330-032) supplemented with 5% horse serum (Sigma, #H1138), 20 ng/ml EGF (R&D Systems, #236-EG), 0.5 µg/ml hydrocortisone (Sigma, #H-4001), 100 ng/ml cholera toxin (Sigma, #C8052), 10 µg/ml insulin (Sigma, #I9278), and 1% Penicillin/Streptomycin (Invitrogen, #15070-063). For experiments involving EGF perturbation, a growth factor-free medium was prepared using DMEM/F12, 5% horse serum, 0.5 µg/ml hydrocortisone, 100 ng/ml cholera toxin, and 1% Pen/Strep.</p> <p>Cells were cultured to 50–80% confluency before being detached with 0.05% trypsin-EDTA (Thermo Fisher Scientific, #25300-054). Subsequently, 20,000 cells were seeded into 24-well plates (Thermo Fisher Scientific, #267062) coated with collagen-1 (Cultrex, #3442-050-01) in growth medium. After six hours, the cells were rinsed with PBS, and the medium was replaced with growth factor-free medium. Following an 18-hour period of growth factor deprivation, cells were treated with either PBS or 10 ng/ml EGF (R&D Systems, #236-EG).</p> <p>Phenotypic responses to EGF treatment were assessed through live-cell imaging using the Incucyte S3 microscope (Essen BioScience, #4647), which captured images every 30 minutes over a 24-hour period. The dataset includes an Excel spreadsheet that documents the experimental conditions for each imaged well.</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Croatia
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Croatia. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Croatian Food Agency</p> <p>VMPR_2022 – Croatian Food Agency</p> <p>VMPR_2021 – Croatian Food Agency</p> <p>VMPR_2020 – Croatian Food Agency</p> <p>VMPR_2019 – Croatian Food Agency</p> <p>VMPR_2018 – Croatian Food Agency</p> <p>VMPR_2017 – Croatian Food Agency</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Ireland
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Ireland. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2022 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2021 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2020 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2019 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2018 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2017 – Department of Agriculture, Food and the Marine</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Finland
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Finland. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Finnish Food Authority</p> <p>VMPR_2022 – Finnish Food Authority</p> <p>VMPR_2021 – Finnish Food Authority</p> <p>VMPR_2020 – Finnish Food Authority</p> <p>VMPR_2019 – Finnish Food Authority</p> <p>VMPR_2018 – Finnish Food Authority</p> <p>VMPR_2017 – Finnish Food Authority</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Greece
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Greece. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Ministry of Rural Development and Food</p> <p>VMPR_2022 – Ministry of Rural Development and Food</p> <p>VMPR_2021 – Ministry of Rural Development and Food</p> <p>VMPR_2020 – Ministry of Rural Development and Food</p> <p>VMPR_2019 – Ministry of Rural Development and Food</p> <p>VMPR_2018 – Ministry of Rural Development and Food</p> <p>VMPR_2017 – Ministry of Rural Development and Food</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Luxembourg
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Luxembourg. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Veterinary Service Administration</p> <p>VMPR_2022 – Veterinary Service Administration</p> <p>VMPR_2021 – Veterinary Service Administration</p> <p>VMPR_2020 – Veterinary Service Administration</p> <p>VMPR_2019 – Veterinary Service Administration</p> <p>VMPR_2018 – Veterinary Service Administration</p> <p>VMPR_2017 – Veterinary Service Administration</p> <p> </p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Cyprus
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Cyprus. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – State General Laboratory - Ministry of Health</p> <p>VMPR_2022 – State General Laboratory - Ministry of Health</p> <p>VMPR_2021 – State General Laboratory - Ministry of Health</p> <p>VMPR_2020 – State General Laboratory - Ministry of Health</p> <p>VMPR_2019 – State General Laboratory - Ministry of Health</p> <p>VMPR_2018 – State General Laboratory - Ministry of Health</p> <p>VMPR_2017 – State General Laboratory - Ministry of Health</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Latvia
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Latvia. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2022 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2021 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2020 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2019 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2018 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2017 – Institute of Food Safety, Animal Health and Environment</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Slovakia
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Slovakia. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2022 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2021 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2020 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2019 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2018 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2017 – State Veterinary and Food Administration of the Slovak Republic</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - The Netherlands
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of The Netherlands. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Netherlands Food and Consumer Product Safety Authority</p> <p>VMPR_2022 – Netherlands Food and Consumer Product Safety Authority</p> <p>VMPR_2021 – Netherlands Food and Consumer Product Safety Authority</p> <p>VMPR_2020 – National Institute for Public Health and the Environment</p> <p>VMPR_2019 – National Institute for Public Health and the Environment </p> <p>VMPR_2018 – National Institute for Public Health and the Environment</p> <p>VMPR_2017 – National Institute for Public Health and the Environment</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.